AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,425,000 | -91.5% | 253,698 | -84.8% | 0.80% | -88.0% |
| Q4 2019 | $40,429,000 | +25.8% | 1,672,714 | 0.0% | 6.66% | -2.1% |
| Q3 2019 | $32,150,000 | -35.0% | 1,672,714 | 0.0% | 6.80% | -75.5% |
| Q2 2019 | $49,429,000 | -37.8% | 1,672,714 | 0.0% | 27.79% | -22.5% |
| Q1 2019 | $79,454,000 | +31.6% | 1,672,714 | 0.0% | 35.87% | +12.1% |
| Q4 2018 | $60,385,000 | -33.0% | 1,672,714 | +14.2% | 32.00% | -4.1% |
| Q3 2018 | $90,155,000 | -8.9% | 1,464,749 | 0.0% | 33.37% | -4.3% |
| Q2 2018 | $98,944,000 | +9.0% | 1,464,749 | -12.4% | 34.86% | +15.5% |
| Q1 2018 | $90,745,000 | -9.2% | 1,672,714 | 0.0% | 30.18% | -13.6% |
| Q4 2017 | $99,945,000 | +22.9% | 1,672,714 | 0.0% | 34.92% | +6.0% |
| Q3 2017 | $81,294,000 | -7.5% | 1,672,714 | 0.0% | 32.95% | -18.2% |
| Q2 2017 | $87,901,000 | +23.2% | 1,672,714 | +6.3% | 40.27% | +31.6% |
| Q1 2017 | $71,337,000 | +19.7% | 1,573,026 | -0.1% | 30.60% | +2.3% |
| Q4 2016 | $59,604,000 | -5.6% | 1,574,749 | -5.9% | 29.91% | -0.8% |
| Q3 2016 | $63,128,000 | +267.8% | 1,672,714 | +71.5% | 30.14% | +156.9% |
| Q2 2016 | $17,165,000 | +48.7% | 975,285 | +2.7% | 11.73% | +107.7% |
| Q1 2016 | $11,544,000 | -35.8% | 949,372 | +28.6% | 5.65% | -6.3% |
| Q4 2015 | $17,979,000 | +11.8% | 738,361 | -18.5% | 6.03% | +23.5% |
| Q3 2015 | $16,078,000 | +13.1% | 906,317 | +12.6% | 4.88% | -2.1% |
| Q2 2015 | $14,212,000 | +115.9% | 805,217 | +283.3% | 4.99% | +27.9% |
| Q1 2015 | $6,583,000 | +2.5% | 210,067 | -4.5% | 3.90% | -11.3% |
| Q4 2014 | $6,424,000 | – | 220,067 | – | 4.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|